Healthcare Industry - Medical - Pharmaceutical - Biotech in Boston, United States
4th ADC Linker and Conjugation Summit
Boston
Tuesday, July 28, 2026
0800
- 1600
2699.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
ADC innovation is accelerating beyond traditional cytotoxins into dual-payload constructs, high-DAR species, degrader-antibody conjugates, and next-generation modalities. However, this rapid evolution is placing unprecedented pressure on linker architecture and conju ..
3rd Structure-Based Drug Design Summit Boston
Boston
Sunday, July 26, 2026
0800
- 1700
2299.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
As drug discovery pipelines face tighter budgets and greater pressure to deliver confident decisions earlier, structure-based drug design is becoming a central driver of modern R and D strategy. Biopharma teams are increasingly combining high-resolution structural bi ..
Autoimmune Neuromuscular and Nerve Disorders Drug Development Summit
Boston
Tuesday, July 21, 2026
0900
- 1700
2699.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Over the past year, the Myasthenia Gravis landscape has transformed from a once-sparse market into a highly competitive, multi-billion-dollar arena, driven by breakthroughs in FcRn inhibition, complement targeting and B-cell modulation. This surge has sparked growing ..
5th Liquid Biopsy for Precision Oncology East Coast
Boston
Monday, July 20, 2026
1500
- 1710
0.50 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Reconvene with the wider liquid biopsy community at the 5th Liquid Biopsy for Precision Oncology Summit East Coast, your laser-focused forum accelerating the real-world application and adoption of liquid biopsies.
Prepare for the most strategic meeting yet, with c ..
6th mRNA-Based Therapeutics Summit
Boston
Monday, July 20, 2026
0800
- 1700
2699.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
From recent acquisitions - including Eli Lilly and Orna, BMS and Orbital, AbbVie and Capstan and BioNTech and CureVac - the mRNA landscape is evolving fast, with assets in in vivo CAR-T, gene editing, and cancer immunotherapies advancing toward clinical validation an ..
4th Obesity and Weight Loss Drug Development 2026
Boston
Tuesday, July 14, 2026
0900
- 1700
2299.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Advancing Personalized, Next-Generation Therapeutics to Redefine Metabolic Quality to Accelerate the Shift From Acute Weight Loss to Sustainable Disease Modification by Demonstrating Durable, Best-in-Class Therapeutic Impact.
Welcome to the 4th Obesity and Weight ..
10th R and D Procurement and Sourcing in Pharma Summit
Boston
Tuesday, June 2, 2026
0830
- 1700
2699.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Establish Procurement Excellence for R and D Innovation, Drive Supplier Value and Accelerate Study Timelines Through AI and Strategic Initiatives.
R and D procurement is undergoing a major transformation as organizations shift from transactional buying to strategi ..
5th ALS Drug Development Summit 2026
Boston
Tuesday, June 2, 2026
0800
- 1700
2299.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Bolstering a Resurgence in Novel Approaches to Target Underlying Pathology, Address Disease Heterogeneity and Restore Hope in a More Transformative Wave of ALS and FTD Therapies.
Uniting ALS Biotech, Pharma and Academia to Accelerate the Next Generation of ALS and ..
5th Circular and SaRNA Therapeutics Summit 2026
Boston
Tuesday, May 26, 2026
0800
- 1700
2699.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
The 5th Circular and Self-Amplifying RNA Therapeutics Summit is the only industry forum dedicated exclusively to translating circRNA and saRNA into durable, IND-ready medicines. As the RNA field moves beyond linear mRNA, these next-generation modalities are emerging ..
4th Nasal Formulation and Delivery Summit
Boston
Tuesday, May 19, 2026
0800
- 1535
2699.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
The 4th Nasal Formulation and Delivery Summit is uniting formulation, delivery, and product development leaders from across pharma and biotech to advance the development of safe, effective, and commercially viable intranasal therapies. As intranasal delivery gains va ..
7th TCR-Based Therapies Summit
Boston
Monday, May 18, 2026
0830
- 1700
2699.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
The past few years for the TCR community have been dynamic. Approvals have signalled a viable path to commercialization, while a wave of company closures highlight the deep-rooted challenges in the current development processes. The message is clear: success is not g ..
Investigative and Preclinical Toxicology Summit 2026
Boston
Tuesday, May 12, 2026
0800
- 1700
2299.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Benchmark Existing Models and Interrogate Practical Applications of NAMs to Accelerate More Predictive In Vitro, In Vivo, and Computational Models
With nearly 90% of drug candidates failing in the clinic, and one-third of those failures driven by safety, toxicology ..
3rd Measuring Patient Engagement Summit
Boston
Tuesday, May 5, 2026
0800
- 1620
2699.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Patient engagement is no longer optional - it's a strategic imperative.
Regulators expect defensible evidence, executives demand clear ROI, and tighter funding and portfolio scrutiny mean every engagement activity must demonstrate real value. Yet across the indust ..
11th 3D Tissue Models Summit 2026
Boston
Tuesday, April 28, 2026
0900
- 1605
2699.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Regulatory and governmental momentum is forcing change, fast:
The Senate have recently cleared the FDA Modernization Act 3.0
The FDA have developed a roadmap that’s abandoning animal testing for mAbs
NIH have closed the door on animal-only grants
The UK join th ..
3rd Peptide-Based Therapeutics Summit 2026
Boston
Tuesday, April 28, 2026
0800
- 1700
2699.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Peptide therapies are rapidly becoming a disruptive modality, led by Merck’s oral PCSK9 inhibitor and Johnson and Johnson’s IL23R, with the hope to develop best-in-class drugs with improved chemistry, formulation and clinical efficacy.
To shine a light on the prog ..
3rd Biophysics for Drug Discovery Summit 2026 at Boston, MA
Boston
Tuesday, April 28, 2026
0830
- 1515
2699.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
AI is transforming every corner of drug discovery, and biophysics is no exception. From predicting molecular interactions to streamlining data analysis with machine learning, AI is enabling faster, more informed early-stage decisions. Meanwhile, experimental biophysi ..
2nd Neuroscience Innovation Partnering and Licensing Summit
Boston
Tuesday, April 28, 2026
0800
- 1500
2699.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
From transformative genetic therapies in rare diseases to neuroimmunology candidates addressing residual unmet needs in MS, and novel target validation driving confidence in disease modification for neurodegeneration, best- and first-in-class neuroscience opportuniti ..
5th ADC Analytical Development Summit
Boston
Tuesday, April 28, 2026
0800
- 1700
2699.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Optimizing ADC Physiochemical, Potency, and Impurity Analytical Methods to Enhance Product Understanding, Quality and Assess DARs for Regulatory Submissions
The 5th ADC Analytical Development Summit is the only dedicated platform for tackling the unique analytical ..
5th GPCRs-Targeted Drug Discovery Summit
Boston
Tuesday, April 28, 2026
0800
- 1700
2699.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
The GPCR field is experiencing a renaissance, driven by renewed investment, clinical progress, and next-generation technologies unlocking hundreds of previously untargeted receptors. With rapid advances in structural biology, computation, and screening, the race is o ..
PFS and Injectable Drug Devices East Coast
Boston
Monday, April 27, 2026
0830
- 1700
3197.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
The conference features a comprehensive pre-conference focus day dedicated to advancements in device design, followed by a dynamic two-day main conference featuring keynote plenaries, interactive panel discussions, and specialized topic streams covering the most pres ..
Measuring Impact in Medical Affairs Summit
Boston
Tuesday, April 21, 2026
0900
- 1700
2699.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
The Measuring Impact in Medical Affairs Summit is uniting Medical Affairs leaders from across pharma and biotech to define, benchmark, and standardize meaningful KPIs that capture the true value of Medical Affairs activities.
As Medical Affairs cements its role as ..
3rd GLP-1-Based Therapeutics Summit 2026
Boston
Tuesday, April 14, 2026
0930
- 1640
2699.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Welcome to the 3rd GLP-1 Based Therapeutics Summit - the essential industry forum dedicated to solving the critical challenges of GLP-1 combinations, mastering tolerability, drug delivery, and seizing the multi-billion dollar opportunity in non-obesity indications.
..
8th Neuroimmunology Drug Development Summit at Wyndham Boston Beacon Hill
Boston
Tuesday, April 14, 2026
0900
- 1700
2699.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Neuroimmunology is entering a defining moment. With the $470M buyout of Vigil’s TREM2 asset, Ventus’ NLRP3 inhibitor in phase 2a, and promising phase 3 BTKi readouts from Sanofi and Roche, the field is beginning to show encouraging signs of clinical viability in targ ..
5th LNP Formulation and Process Development Summit
Boston
Monday, April 6, 2026
0800
- 1700
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
LNPs continue to dominate the spotlight in biopharma with three landmark acquisitions in the past six months, AbbVie/Capstan Therapeutics, Eli Lilly and Co/Verve Therapeutics and Bristol Myers Squibb/Orbital Therapeutics. Validating LNPs as a stand-out delivery vehic ..
9th Gene Therapy Development Summit 2026
Boston
Tuesday, March 24, 2026
0800
- 1800
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Gene therapy is entering a defining new chapter. After a period of challenge and recalibration, the field is regaining momentum, driven by teams who remain steadfast in their belief that this science can transform lives. Confidence is returning, with significant inve ..
3rd DNA Process Development and Manufacturing Summit
Boston
Tuesday, March 24, 2026
0800
- 1700
2699.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Cutting-edge breakthroughs in DNA production, from high-yield plasmid manufacturing to next-generation cell-free platforms, are transforming how biopharma develops advanced vaccines and nucleic acid-based therapeutics. Organizations across the space are accelerating ..
Immune Resetting: B-Cell Mediated and Beyond
Boston
Tuesday, March 24, 2026
0800
- 1700
2699.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
The era of blanket immunosuppression is ending. A new chapter in autoimmune therapy is unfolding, one where precision replaces broad suppression, and immune resetting takes centre stage. B-cell depletion therapies have paved the way, but the question remains: what's ..
Pharma Forum 2026: Medical Meetings Mastered
Boston
Sunday, March 22, 2026
0930
- 1530
Free
Healthcare Industry - Medical - Pharmaceutical - Biotech
Pharma Forum: The Premier Conference for Life Sciences Meeting Professionals
Pharma Forum is the ultimate gathering for professionals in the life sciences industry who specialize in planning, managing, and executing meetings and events. This dynamic conference is ..
5th Novel Conjugates Summit
Boston
Tuesday, March 17, 2026
0800
- 1600
2699.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Novel conjugates have become one of the most competitive and rapidly evolving areas in the precision oncology landscape. Companies are looking beyond traditional ADCs towards novel mechanism of action payloads and differentiated targeting formats for overcoming drug ..
9th Antigen-Specific Immune Tolerance Summit at Boston, MA
Boston
Tuesday, March 3, 2026
0900
- 1700
2699.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Uniting 60+ leaders from cutting-edge biotechs to global pharma, this summit delivers comprehensive insight across antigen selection, biomarker strategy, B-cell and cellular tolerance mechanisms, delivery platforms, and clinical trial execution.
The 2026 agenda sp ..
Measuring Impact in Medical Affairs Summit
Boston
Tuesday, February 24, 2026
0900
- 1700
2199.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
The Measuring Impact in Medical Affairs Summit is uniting Medical Affairs leaders from across pharma and biotech to define, benchmark, and standardize meaningful KPIs that capture the true value of Medical Affairs activities.
As Medical Affairs cements its role as ..
5th mRNA Analytical Development and Quality Control Summit
Boston
Tuesday, February 24, 2026
0800
- 1800
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
As the mRNA field evolves beyond vaccines into diverse modalities, delivery systems, and therapeutic areas, analytical rigor has never been more critical. With the FDA intensifying scrutiny on CMC packages and new draft guidelines emerging from the EMA, USP, NIST, an ..
7th Glioblastoma Drug Development Summit
Cambridge
Tuesday, February 17, 2026
0830
- 1730
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Innovating Novel Combination Therapies and Maximising Preclinical and Clinical Development to Improve Glioblastoma Targeting and Increase Investment Opportunities to Ultimately Bring Efficacious Therapies to Patients in Need
The glioblastoma drug development space h ..
2nd Proteomic Based Drug Discovery Summit 2026
Boston
Tuesday, February 3, 2026
0800
- 1615
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
With Novartis committing $750M to ProFound Therapeutics to discover new cardiovascular candidates, and Illumina acquiring SomaLogic for $425 to expand its proteomic capabilities just this year alone, the increasing recognition of proteomics as a transformative force ..
14th Alzheimer's and Parkinson's Drug Development Summit
Boston
Tuesday, February 3, 2026
0800
- 1700
2199.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
The approval of the first anti-amyloid drugs has resurrected the neurodegenerative disease space, opening the door for enhanced competition and innovation to develop novel disease-modifying therapies. However, as challenges remain in the clinical adoption of Lecanema ..
Non-Opioid Pain Therapeutics Summit
Boston
Tuesday, January 27, 2026
0900
- 1500
2199.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
For more than two decades, biopharma has struggled to develop safe and effective non-opioid pain therapies. With Vertex’s recent approval marking a long-awaited breakthrough, the momentum has reached a critical point for bringing non-opioid pain therapeutics to marke ..
9th DDR Inhibitors Summit
Boston
Tuesday, January 27, 2026
0830
- 1700
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Returning to Boston for its 9th year, the DDR Inhibitors Summit is the definitive industry forum for drug developers advancing DNA Damage Response (DDR)-targeted therapies. With PARP inhibitors now clinically validated, the field is rapidly evolving to explore novel ..
4th Molecular Glue Drug Development Summit | Boston, MA | January 27-29, 2026
Boston
Tuesday, January 27, 2026
0830
- 1545
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Enabling Rapid Target Selection, Discovery and Rational Design of Degrading and Non-Degrading Molecular Glue to Develop Potent, Selective and Safer Cures for Cancer and Beyond.
Molecular glues are leading the charge in the race to drug the previously undruggable, ..
7th RNAi-Based Therapeutics Summit
Boston
Tuesday, January 27, 2026
0800
- 1630
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Discover, Develop and Selectively Deliver Highly Stable and Potent RNAi Therapeutics for Targeted and Effective Gene Silencing in Oncology, Rare, Cardiovascular Disorders and Beyond
The 7th RNAi-Based Therapeutics Summit is the industry's premier dedicated forum f ..
3rd Covalent Drug Discovery and Development Summit
Boston
Tuesday, December 9, 2025
0900
- 1515
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
2025 marks an exciting phase for covalent drugs, with the field doubling down on de-risked assets and tackling high-value targets in oncology, immunology, and beyond. With MOMA Therapeutics recently dosing their first patient with a covalent Werner helicase inhibitor ..
7th CNS Drug Delivery Summit
Boston
Tuesday, December 9, 2025
0800
- 1630
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Despite milestones such as Roche's Trontinemab Brainshuttle™ achieving robust amyloid clearance, challenges remain in reaching targeted brain regions, improving predictive modelling, ensuring efficacy and penetrance, and developing safer, targeted delivery approaches ..
Oligonucleotide-based Therapeutics Summit
Boston
Tuesday, December 9, 2025
0800
- 1700
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
Delivering Oligonucleotides with Specificity, Mitigating Off-Target Effects, and Improving Cellular Uptake to Target Undruggable Molecules.
The Oligonucleotide-based Therapeutics Summit is uniting leaders in RNA chemistry, delivery science, and translational biolo ..
2nd ADC Pharmacokinetics and Clinical Pharmacology Summit | December 9-11, 2025 | Boston, MA
Boston
Tuesday, December 9, 2025
0800
- 1700
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
As ADC approvals grow and pipelines expand, dose selection has become one of the field’s biggest challenges, and Project Optimus has resulted in pushing developers to move beyond maximum tolerated dose and define regimens that truly balance safety and efficacy.
In ..
Designing the AI-Enabled Biopharma Workforce Summit 2025
Boston
Tuesday, December 2, 2025
0800
- 1730
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
As AI reshapes the biopharma landscape, nearly every role within our organizations is poised for transformation - but the path forward remains uncertain. What is clear, however, is that the future hinges on the choices we make today.
The most innovative companies, ..
8th RNA-Targeted Drug Discovery and Development Summit
Boston
Tuesday, December 2, 2025
0700
- 1800
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
RNA-targeting small molecules are rapidly emerging as a powerful therapeutic reality. From modulating splicing to directly binding RNAs, these molecules offer a revolutionary approach to treating previously undruggable diseases across neurodegenerative, cancer and ra ..
9th Complement-Based Drug Development Summit
Boston
Monday, December 1, 2025
0800
- 1640
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
So far, 2025 has brought significant excitement and progress to the complement-based therapeutic landscape. Leading biopharma companies like Novartis, Annexon Biosciences and Omeros, are making significant clinical progress in PNH, AMD, IgAN and C3G, whilst key acade ..
7th Cell Therapy Analytical Development Summit
Boston
Monday, December 1, 2025
0800
- 1700
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
With robust, reliable and regulatory-ready analytics lying at the heart of clinically successful cell therapies, now is the time to elevate your current workflows and strategies to prepare for clinical and commercial readiness.
Remaining the industry’s leading for ..
9th Dermatology Drug Development Summit
Boston
Tuesday, November 18, 2025
0900
- 1605
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
The Industry’s Destination to Discover and Develop Best-In-Class Drugs for Immuno-Inflammatory Skin Disease.
As the field surges with clinical and commercial momentum, from Sanofi’s continued success with Dupixent, Corvus' promising Phase 1 data on Soquelitinib, a ..
2nd Annual Personalized Cancer Vaccine Summit
Boston
Tuesday, November 18, 2025
0830
- 1740
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
With industry eagerly anticipating readouts from Merck and Moderna’s Phase 3 trial of adjuvant V940 in combination with Keytruda, BioNTech, and Genentech’s global trials for BNT116 for non-small cell lung cancer, we are advancing ever closer to a commercially approve ..
Model-Informed Drug Development Summit
Boston
Tuesday, November 18, 2025
0800
- 1545
2599.00 USD
Healthcare Industry - Medical - Pharmaceutical - Biotech
The Model-Informed Drug Development Summit is the first and only industry-focused, 3-day strategic meeting on how MIDD is reshaping decision-making and accelerating success in drug development. With the release of the draft ICH M15 guidelines and the FDA’s move to ph ..